Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Easywell Biomedicals, Inc. (1799) Income Statement

Easywell Biomedicals, Inc. Income Statement

Last quarter (Q2 2026), Easywell Biomedicals, Inc.'s total revenue was NT$226.63M, an increase of 107.44% from the same quarter last year. In Q2, Easywell Biomedicals, Inc.'s net income was NT$-12.46M. See Easywell Biomedicals, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 597.41MNT$ 540.44MNT$ 271.63MNT$ 178.90MNT$ 197.28M
NT$ 245.71MNT$ 299.40MNT$ 170.72MNT$ 76.31MNT$ 50.43M
NT$ 312.91MNT$ 369.21MNT$ 333.46MNT$ 237.57MNT$ 262.29M
Depreciation and AmortizationNT$ 91.13MNT$ 79.88MNT$ 65.15MNT$ 66.55MNT$ 70.88M
NT$ 23.93MNT$ 12.75MNT$ -85.50MNT$ -84.48MNT$ -82.70M
NT$ -67.20MNT$ -69.81MNT$ -162.74MNT$ -151.03MNT$ -153.58M
NT$ -7.98MNT$ -18.47MNT$ -7.17MNT$ -7.02MNT$ 42.20M
NT$ -75.18MNT$ -88.29MNT$ -169.91MNT$ -168.28MNT$ -169.66M
NT$ -73.14MNT$ -97.47MNT$ -144.82MNT$ -161.00MNT$ -150.39M
Per Share Metrics
Basic EPSNT$ -0.59NT$ -0.81NT$ -1.27NT$ -1.39NT$ -1.44
Diluted EPSNT$ -0.59NT$ -0.81NT$ -1.27NT$ -1.39NT$ -1.44
Weighted Average Shares Outstanding123.96M120.18M114.42M115.62M104.12M
Weighted Average Shares Outstanding (Diluted)123.96M120.18M114.42M115.62M104.12M

Currency in TWD

Easywell Biomedicals, Inc. Earnings and Revenue History

-400M0400M800M-120 %-80 %-40 %0 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin